JP2004522780A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004522780A5 JP2004522780A5 JP2002567302A JP2002567302A JP2004522780A5 JP 2004522780 A5 JP2004522780 A5 JP 2004522780A5 JP 2002567302 A JP2002567302 A JP 2002567302A JP 2002567302 A JP2002567302 A JP 2002567302A JP 2004522780 A5 JP2004522780 A5 JP 2004522780A5
- Authority
- JP
- Japan
- Prior art keywords
- stable pharmaceutical
- pharmaceutical formulation
- torsemide
- torsemide modification
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 claims 19
- 229960005461 torasemide Drugs 0.000 claims 19
- 230000004048 modification Effects 0.000 claims 14
- 238000012986 modification Methods 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 238000004090 dissolution Methods 0.000 claims 3
- 238000009826 distribution Methods 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 229960004977 anhydrous lactose Drugs 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 229940069328 povidone Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18328800P | 2000-02-17 | 2000-02-17 | |
| PCT/US2001/005577 WO2002067935A1 (en) | 2000-02-17 | 2001-02-21 | A stable pharmaceutical formulation comprising torsemide modification ii |
| US09/789,424 US6482417B2 (en) | 2000-02-17 | 2001-02-21 | Stable pharmaceutical formulation comprising torsemide modification II |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004522780A JP2004522780A (ja) | 2004-07-29 |
| JP2004522780A5 true JP2004522780A5 (enExample) | 2006-01-05 |
Family
ID=27359046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567302A Withdrawn JP2004522780A (ja) | 2000-02-17 | 2001-02-21 | トルセミド・モディフィケーションｉｉを含む安定な医薬品製剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6482417B2 (enExample) |
| EP (1) | EP1292303B1 (enExample) |
| JP (1) | JP2004522780A (enExample) |
| CN (1) | CN1505512A (enExample) |
| AT (1) | ATE266404T1 (enExample) |
| CA (1) | CA2410802A1 (enExample) |
| DE (2) | DE1292303T1 (enExample) |
| DK (1) | DK1292303T3 (enExample) |
| ES (1) | ES2193007T3 (enExample) |
| HR (1) | HRP20030762A2 (enExample) |
| HU (1) | HUP0600143A2 (enExample) |
| IL (1) | IL157539A0 (enExample) |
| IS (1) | IS6919A (enExample) |
| MX (1) | MXPA03007908A (enExample) |
| NO (1) | NO20033699L (enExample) |
| PT (1) | PT1292303E (enExample) |
| SI (1) | SI1292303T1 (enExample) |
| SK (1) | SK11632003A3 (enExample) |
| TR (1) | TR200401462T4 (enExample) |
| WO (1) | WO2002067935A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013289A1 (de) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Torasemid enthaltende pharmazeutische Zubereitungen |
| US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
| ITMI20020639A1 (it) | 2002-03-27 | 2003-09-29 | Cosma S P A | Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea |
| WO2005044187A2 (en) * | 2003-10-28 | 2005-05-19 | Glaxo Group Limited | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| ES2244324B1 (es) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | Composiciones diureticas de liberacion prolongada. |
| CN100421662C (zh) * | 2005-11-08 | 2008-10-01 | 周卓和 | 托拉塞米分散片及其制备方法和应用 |
| CN100372534C (zh) * | 2006-04-20 | 2008-03-05 | 南京海辰药业有限公司 | 托拉塞米冻干制剂及制备方法 |
| US20080213362A1 (en) * | 2007-02-02 | 2008-09-04 | Lawrence Solomon | Compositions and methods using torsemide |
| CN106038500A (zh) * | 2016-05-26 | 2016-10-26 | 南京正科医药股份有限公司 | 一种托拉塞米片 |
| GR1010905B (el) * | 2024-04-15 | 2025-03-10 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια, | Δισκιο που περιεχει τορασεμιδη |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1477664A (en) | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
| DE3529529A1 (de) | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| NZ302926A (en) * | 1995-02-28 | 1998-10-28 | Hoechst Marion Roussel Inc | Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients |
| US5914336A (en) * | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
| US6465496B1 (en) * | 1999-08-11 | 2002-10-15 | Teva Pharmaceutical Industries, Ltd. | Torsemide polymorphs |
-
2001
- 2001-02-21 CA CA002410802A patent/CA2410802A1/en not_active Abandoned
- 2001-02-21 DE DE1292303T patent/DE1292303T1/de active Pending
- 2001-02-21 MX MXPA03007908A patent/MXPA03007908A/es not_active Application Discontinuation
- 2001-02-21 CN CNA018231683A patent/CN1505512A/zh active Pending
- 2001-02-21 IL IL15753901A patent/IL157539A0/xx unknown
- 2001-02-21 DE DE60103276T patent/DE60103276T2/de not_active Expired - Fee Related
- 2001-02-21 DK DK01911078T patent/DK1292303T3/da active
- 2001-02-21 AT AT01911078T patent/ATE266404T1/de not_active IP Right Cessation
- 2001-02-21 JP JP2002567302A patent/JP2004522780A/ja not_active Withdrawn
- 2001-02-21 TR TR2004/01462T patent/TR200401462T4/xx unknown
- 2001-02-21 HU HU0600143A patent/HUP0600143A2/hu unknown
- 2001-02-21 EP EP01911078A patent/EP1292303B1/en not_active Revoked
- 2001-02-21 HR HR20030762A patent/HRP20030762A2/xx not_active Application Discontinuation
- 2001-02-21 US US09/789,424 patent/US6482417B2/en not_active Expired - Fee Related
- 2001-02-21 PT PT01911078T patent/PT1292303E/pt unknown
- 2001-02-21 SK SK1163-2003A patent/SK11632003A3/sk not_active Application Discontinuation
- 2001-02-21 WO PCT/US2001/005577 patent/WO2002067935A1/en not_active Ceased
- 2001-02-21 SI SI200130132T patent/SI1292303T1/xx unknown
- 2001-02-21 ES ES01911078T patent/ES2193007T3/es not_active Expired - Lifetime
-
2003
- 2003-08-20 IS IS6919A patent/IS6919A/is unknown
- 2003-08-20 NO NO20033699A patent/NO20033699L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7374781B2 (en) | Sustained release formulations containing acetaminophen and tramadol | |
| JP4077320B2 (ja) | ５−メチル−１−フェニル−２−（１ｈ）−ピリドンを有効成分として含有する医薬製剤 | |
| US5672356A (en) | Bioadhesive pharmaceutical composition for the controlled release of active principles | |
| JP2009545560A5 (enExample) | ||
| AU606149B2 (en) | Pharmaceutical formulations | |
| US5814339A (en) | Film coated tablet of paracetamol and domperidone | |
| JP2005512995A5 (enExample) | ||
| JPS6330427A (ja) | 徐放性の経口医薬用固形組成物及びその調製基剤 | |
| RU99107283A (ru) | Не содержащие лактозы, негигроскопичные и безводные фармацевтические препараты дескарбоэтоксилоратадина | |
| WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
| CN101073563B (zh) | 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片 | |
| JP2010511663A5 (enExample) | ||
| WO2010128525A4 (en) | A formulation of ivabradine for treating the cardiovascular disease | |
| CN101703513A (zh) | 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂 | |
| Ge et al. | Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin | |
| JPS6241646B2 (enExample) | ||
| JP2004522780A5 (enExample) | ||
| NO320022B1 (no) | Kontrollert frigjorende farmasoytisk preparat med tilidinmesylat som virkestoff | |
| WO2014209087A1 (en) | Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin | |
| WO1997033574A1 (fr) | Comprimes a liberation prolongee a base de valproate metallique | |
| DE60006362D1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
| JP2011516544A5 (enExample) | ||
| WO2012029838A1 (ja) | 口腔内崩壊錠 | |
| ES2321908T3 (es) | Preparaciones farmaceuticas de liberacion prolongada independientemente del ph. | |
| JP2012140335A (ja) | 不快味マスキング粒子及びこれを含有する経口製剤 |